Memory: Diversity on location
The RNA binding protein FMRP regulates the synthesis of synaptic and nuclear proteins within different compartments of a neuron.
- Department of Neuroscience, Albert Einstein College of Medicine, United States
- Department of Cell Biology, Emory University School of Medicine, United States
Our fascination with memory dates to antiquity and has not ceased in modern days. While it is relatively straightforward to demonstrate how cognitive associations are formed, the underlying cellular and molecular processes are much harder to pin down.
When the brain forms memories or learns new tasks, the synaptic connections between the neurons are either strengthened or weakened in a process known as plasticity. To remodel synaptic connections and stabilize newly made memories, more proteins must be made: consequently, the way that gene expression is regulated in specific neurons within the hippocampus changes.
Previous research has shown that messenger RNA molecules (mRNAs) are transported to different parts of the neuron, such as the axons and dendrites (the projections of a neuron sending or receiving signals to and from other neurons), whereas others remain in the cell body (Holt et al., 2019). Each localized mRNA acts as a template to make new proteins and thus, local protein synthesis drives plasticity in hippocampal neurons. But exactly how gene expression via mRNA sorting is regulated in the different parts of the neuron has been less clear.
Neurogenetic diseases that lack essential regulators of gene expression may provide clues on how proteins are produced in the correct place, or taken there, during learning and memory. For example, people with Fragile X Syndrome (FXS), a genetic condition that causes intellectual disability and autism, lack the mRNA binding protein FMRP (Santoro et al., 2012). In healthy individuals, FMRP is widely distributed throughout the neuron, where it can regulate the translation of mRNAs to make new proteins and control other aspects of the post-transcriptional process, including the transport and stability of mRNA (Bassell and Warren, 2008). Moreover, FMRP can often repress translation, keeping the mRNA silent until proteins are needed. Upon synaptic stimulation, FMRP’s repressive role is relieved, allowing ribosomes to make new proteins locally.
In FXS, the loss of FMRP causes an overproduction of proteins, which can affect the development and plasticity of synapses (Figure 1; Richter et al., 2015). Since FMRP can travel in and out of the nucleus and to the synapses, it could be an ideal candidate to control the translation of mRNAs into proteins relevant for both nuclear and synaptic roles. However, it has so far been unclear how FMRP could achieve this.
Figure 1
Compartment-specific regulation of mRNA translation by FMRP in neurons.
Hale et al. found that the mRNA binding protein FMRP plays an expanded role in regulating protein synthesis in hippocampal CA1 neurons (left). In the cell body (top inset), FMRP (green circle) binds and blocks the translation of synaptic (magenta) and chromatin regulator mRNA (blue and gold). Without FMRP, the stability and/or translation of its target mRNA in the cell body is altered. In the dendrite (bottom inset), FMRP represses the translation of synaptic regulator mRNA, consistent with the role of FMRP to modulate protein synthesis. This suggests that FMRP can interact with different populations of mRNA within subcellular compartments to both reversibly repress translation and regulate the availability of mRNA for protein synthesis.
Now, in eLife, Robert Darnell and colleagues at The Rockefeller University – including Caryn Hale as first author – report that FMRP plays different roles in specific parts of a neuron (Hale et al., 2021). The team created genetically modified mice to analyze mRNAs from the dendrites and the cell bodies of hippocampal neurons involved in memory, known as excitatory CA1 pyramidal neurons. Three variations of genetically modified mice were used in which specific proteins were tagged with fluorescent markers to track and identify where mRNAs are present; how much of these mRNAs were present, whether they were associated with ribosomes needed for translation, and whether these mRNAs were bound to FMRP in different regions (i.e., dendrites and cell bodies). In another set of experiments, Hale et al. further compared wild type mice with a functional FMRP protein to mice without FMRP to identify dysregulated mRNAs relevant to FXS (Figure 1).
This revealed that FMRP regulates distinct populations of mRNAs in the dendrites and the cell bodies. In the dendrites, FMRP predominantly coordinates the translation of synaptic proteins, which can affect how a neuron responds to signals and may alter the strength of the synapses. In the cell bodies, FMRP controls the translation of proteins that are subsequently trafficked to the cell nucleus, including proteins that regulate the activity of genes. This is consistent with previous studies showing that FMRP can regulate the expression of both nuclear and synaptic proteins (Korb et al., 2017; Richter et al., 2015). However, it was not known that FMRP regulates these two disparate classes of mRNAs in a compartment specific manner.
Hale et al. further demonstrate that FMRP preferentially binds to mRNA isoforms, which encode for the same protein, but have different, untranslated regions at the end of the transcript involved in translational regulation. In connection with FMRP, the isoforms may influence the stability or the translation of mRNAs within specific parts of the neuron, but it remains to be seen how exactly FMRP regulates the selective translation of distinct mRNA isoforms in a sequence-specific manner (Tushev et al., 2018). Contrary to other studies, no specific role for RNA sequence motifs or secondary structures (which would help RNA binding proteins to recognize specific mRNAs) was found (Ascano et al., 2012; Goering et al., 2020).
Moreover, the study of Hale et al. indicates that FMRP does not appear to be necessary for localizing mRNAs to the dendrites, as the mRNAs found there were the same in mice both with and without FMRP. This is consistent with an earlier report (Steward et al., 1998) and suggests that other RNA binding proteins may be involved in transporting mRNAs. More research is needed to better understand the mechanisms of FMRP selectivity and how its targets are directly transported.
Consistent with previous research, a main conclusion from the work of Hale et al. is that the lack of FMRP in mice models for FXS leads to a regulatory loss of protein production in different neuronal compartments, which affects synaptic plasticity, learning and memory (Figure 1). The large datasets generated by Hale et al., and their innovative technique of tracking mRNAs (and their activity) in neurons, have revealed that these cells employ transcriptional and post-transcriptional mechanisms to differentially regulate protein synthesis throughout the neuron.
Likely, hippocampal neurons involved in memory formation are constantly undergoing changes in gene expression, during which transcripts need to properly localize, some restricted to the cell body and others shipped out to the synapses. This insight may help pave new ways for future studies to identify potential roles for some of these dysregulated mRNAs in FXS and other conditions caused by an altered expression of RNA binding proteins.
References
-
Local translation in neurons: visualization and functionNature Structural & Molecular Biology 26:557–566.https://doi.org/10.1038/s41594-019-0263-5
-
Dysregulation and restoration of translational homeostasis in Fragile X syndromeNature Reviews Neuroscience 16:595–605.https://doi.org/10.1038/nrn4001
-
Molecular mechanisms of Fragile X syndrome: A twenty-year perspectiveAnnual Review of Pathology 7:219–245.https://doi.org/10.1146/annurev-pathol-011811-132457
Article and author information
Author details
Publication history
Copyright
© 2022, Yoon and Bassell
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 948
- views
-
- 87
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Memory: Diversity on location
eLife 11:e76818.
https://doi.org/10.7554/eLife.76818
Further reading
-
- Cancer Biology
- Genetics and Genomics
The expression of eukaryotic genes relies on the precise 3'-terminal cleavage and polyadenylation of newly synthesized pre-mRNA transcripts. Defects in these processes have been associated with various diseases, including cancer. While cancer-focused sequencing studies have identified numerous driver mutations in protein-coding sequences, noncoding drivers – particularly those affecting the cis-elements required for pre-mRNA cleavage and polyadenylation – have received less attention. Here, we systematically analysed somatic mutations affecting 3'UTR polyadenylation signals in human cancers using the Pan-Cancer Analysis of Whole Genomes (PCAWG) dataset. We found a striking enrichment of cancer-specific somatic mutations that disrupt strong and evolutionarily conserved cleavage and polyadenylation signals within tumour suppressor genes. Further bioinformatics and experimental analyses conducted as a part of our study suggest that these mutations have a profound capacity to downregulate the expression of tumour suppressor genes. Thus, this work uncovers a novel class of noncoding somatic mutations with significant potential to drive cancer progression.
-
- Developmental Biology
- Genetics and Genomics
O-GlcNAcylation is an essential intracellular protein modification mediated by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). Recently, missense mutations in OGT have been linked to intellectual disability, indicating that this modification is important for the development and functioning of the nervous system. However, the processes that are most sensitive to perturbations in O-GlcNAcylation remain to be identified. Here, we uncover quantifiable phenotypes in the fruit fly Drosophila melanogaster carrying a patient-derived OGT mutation in the catalytic domain. Hypo-O-GlcNAcylation leads to defects in synaptogenesis and reduced sleep stability. Both these phenotypes can be partially rescued by genetically or chemically targeting OGA, suggesting that a balance of OGT/OGA activity is required for normal neuronal development and function.
